Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Characteristics and mechanism of inotropic and chronotropic actions of bretylium tosylate.

× No keyword cloud information.

8 in total

1. Selective inhibition of K(+)-stimulation of Na,K-ATPase by bretylium.

Authors: P E Tiku; P T Nowell
Journal: Br J Pharmacol Date: 1991-12 Impact factor: 8.739

2. Antiarrhythmic agents. II. Therapeutic considerations.

Authors: D T Mason; A N DeMaria; E A Amsterdam; R Zelis; R A Massumi
Journal: Drugs Date: 1973 Impact factor: 9.546

3. Myocardial inactivity of therapeutic concentrations of hydralazine and diazoxide.

Authors: J Koch-Weser
Journal: Experientia Date: 1974-02-15

Review 4. New antiarrhythmic drugs: their place in therapy.

Authors: D L Keefe; R E Kates; D C Harrison
Journal: Drugs Date: 1981-11 Impact factor: 9.546

Review 5. Adverse effects of antiarrhythmic drugs.

Authors: J B Schwartz; D Keefe; D C Harrison
Journal: Drugs Date: 1981-01 Impact factor: 9.546

6. Preventing ventricular fibrillation by flattening cardiac restitution.

Authors: A Garfinkel; Y H Kim; O Voroshilovsky; Z Qu; J R Kil; M H Lee; H S Karagueuzian; J N Weiss; P S Chen
Journal: Proc Natl Acad Sci U S A Date: 2000-05-23 Impact factor: 11.205

7. Class III antiarrhythmic drugs (amiodarone, bretylium and sotalol) on action potentials and membrane currents in rabbit sino-atrial node preparations.

Authors: H Satoh
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1991-12 Impact factor: 3.000

Review 8. Class III antiarrhythmics in overdose. Presenting features and management principles.

Authors: E W Leatham; D W Holt; W J McKenna
Journal: Drug Saf Date: 1993-12 Impact factor: 5.606

8 in total